Hopper Paul 4
4 · Scopus BioPharma Inc. · Filed Nov 17, 2021
Insider Transaction Report
Form 4
Hopper Paul
Director
Transactions
- Other
Common Stock
2021-06-01+700,000(indirect: By Moreglade Pty. Limited) - Other
Common Stock
2021-06-01+6,333
Footnotes (3)
- [F1]Issued as partial consideration for the sale of Bioscience Oncology Pty. Ltd. to the issuer on June 10, 2020 pursuant to the Conditional Stock Purchase Agreement dated as of June 8, 2020 among the issuer, as purchaser, and Mr. Hopper and the other sellers party thereto, as sellers.
- [F2]Mr. Hopper is a director of Moreglade Pty. Limited and therefore is deemed to have shared voting and dispositive power over the shares of Common Stock held by this entity. Mr. Hopper disclaims beneficial ownership of the shares of Common Stock held by this entity, as he has no pecuniary interest therein.
- [F3]Excludes 12,666 shares owned by Mr. Hopper's spouse and an aggregate of 101,336 shares owned by Mr. Hopper's adult children, as to which shares he disclaims beneficial ownership.